{"entity":{"type":"insider","cik":"0001748265","url":"/insider/0001748265","json_url":"/insider/0001748265.json","name":"Posner Christopher","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":17,"first":"2020-11-23","last":"2025-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Posner Christopher","source":"filing","n_filings":17,"first_seen":"2020-11-23","last_seen":"2025-03-04"}],"transactions":[{"id":4433194,"accession":"0001415889-25-006576","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-006576","line_url":"/filing/0001415889-25-006576#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":583.0,"shares_display":"583","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":2769.25,"total_display":"2,769.25","total_whole":"2,769","shares_owned_after":13109.0,"shares_owned_after_display":"13,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-03-04","scope":"insider"},{"id":4805115,"accession":"0001415889-25-003295","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-003295","line_url":"/filing/0001415889-25-003295#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":372.0,"shares_display":"372","price_per_share":4.72,"price_display":"4.72","price_state":"stated","total_value":1755.84,"total_display":"1,755.84","total_whole":"1,756","shares_owned_after":13692.0,"shares_owned_after_display":"13,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-06","scope":"insider"},{"id":2279944,"accession":"0001415889-24-026248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-026248","line_url":"/filing/0001415889-24-026248#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3668.0,"shares_display":"3,668","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":1063.72,"total_display":"1,063.72","total_whole":"1,064","shares_owned_after":168768.0,"shares_owned_after_display":"168,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-04","filed_date":"2024-11-06","scope":"insider"},{"id":3263061,"accession":"0001415889-24-020605","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-020605","line_url":"/filing/0001415889-24-020605#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4149.0,"shares_display":"4,149","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":1452.15,"total_display":"1,452.15","total_whole":"1,452","shares_owned_after":172436.0,"shares_owned_after_display":"172,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-01","filed_date":"2024-08-02","scope":"insider"},{"id":2999641,"accession":"0001415889-24-012322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-012322","line_url":"/filing/0001415889-24-012322#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3936.0,"shares_display":"3,936","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":2952.0,"total_display":"2,952.00","total_whole":"2,952","shares_owned_after":176585.0,"shares_owned_after_display":"176,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-06","scope":"insider"},{"id":3252154,"accession":"0001415889-24-006273","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-006273","line_url":"/filing/0001415889-24-006273#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5834.0,"shares_display":"5,834","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":5192.26,"total_display":"5,192.26","total_whole":"5,192","shares_owned_after":180521.0,"shares_owned_after_display":"180,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-04","scope":"insider"},{"id":2995465,"accession":"0001415889-24-003395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-003395","line_url":"/filing/0001415889-24-003395#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35575.0,"shares_display":"35,575","price_per_share":0.53,"price_display":"0.53","price_state":"stated","total_value":18854.75,"total_display":"18,854.75","total_whole":"18,855","shares_owned_after":186355.0,"shares_owned_after_display":"186,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-08","filed_date":"2024-02-12","scope":"insider"},{"id":2096090,"accession":"0001415889-24-002513","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-002513","line_url":"/filing/0001415889-24-002513#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4981.0,"shares_display":"4,981","price_per_share":0.55,"price_display":"0.55","price_state":"stated","total_value":2739.55,"total_display":"2,739.55","total_whole":"2,740","shares_owned_after":221930.0,"shares_owned_after_display":"221,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-05","scope":"insider"},{"id":8727139,"accession":"0001209191-23-054332","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054332","line_url":"/filing/0001209191-23-054332#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3796.0,"shares_display":"3,796","price_per_share":1.22,"price_display":"1.22","price_state":"stated","total_value":4631.12,"total_display":"4,631.12","total_whole":"4,631","shares_owned_after":164411.0,"shares_owned_after_display":"164,411","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-02","filed_date":"2023-11-03","scope":"insider"},{"id":8116244,"accession":"0001209191-23-044636","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-044636","line_url":"/filing/0001209191-23-044636#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4307.0,"shares_display":"4,307","price_per_share":3.07,"price_display":"3.07","price_state":"stated","total_value":13222.49,"total_display":"13,222.49","total_whole":"13,222","shares_owned_after":168207.0,"shares_owned_after_display":"168,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-03","filed_date":"2023-08-04","scope":"insider"},{"id":8187540,"accession":"0001209191-23-028247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-028247","line_url":"/filing/0001209191-23-028247#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3869.0,"shares_display":"3,869","price_per_share":4.4,"price_display":"4.40","price_state":"stated","total_value":17023.6,"total_display":"17,023.60","total_whole":"17,024","shares_owned_after":172514.0,"shares_owned_after_display":"172,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-05","filed_date":"2023-05-09","scope":"insider"},{"id":7831372,"accession":"0001209191-23-016796","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016796","line_url":"/filing/0001209191-23-016796#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5987.0,"shares_display":"5,987","price_per_share":9.71,"price_display":"9.71","price_state":"stated","total_value":58133.77,"total_display":"58,133.77","total_whole":"58,134","shares_owned_after":176383.0,"shares_owned_after_display":"176,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-07","scope":"insider"},{"id":8543077,"accession":"0001209191-23-007170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-007170","line_url":"/filing/0001209191-23-007170#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4191.0,"shares_display":"4,191","price_per_share":11.8,"price_display":"11.80","price_state":"stated","total_value":49453.8,"total_display":"49,453.80","total_whole":"49,454","shares_owned_after":182370.0,"shares_owned_after_display":"182,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-02","filed_date":"2023-02-03","scope":"insider"},{"id":6127217,"accession":"0001209191-22-057948","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-057948","line_url":"/filing/0001209191-22-057948#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14470.0,"shares_display":"14,470","price_per_share":11.13,"price_display":"11.13","price_state":"stated","total_value":161051.1,"total_display":"161,051.10","total_whole":"161,051","shares_owned_after":186561.0,"shares_owned_after_display":"186,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-18","scope":"insider"},{"id":6608047,"accession":"0001209191-22-023237","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-023237","line_url":"/filing/0001209191-22-023237#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2006.0,"shares_display":"2,006","price_per_share":12.67,"price_display":"12.67","price_state":"stated","total_value":25416.02,"total_display":"25,416.02","total_whole":"25,416","shares_owned_after":201031.0,"shares_owned_after_display":"201,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-05","scope":"insider"},{"id":4785622,"accession":"0001209191-21-038764","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-038764","line_url":"/filing/0001209191-21-038764#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2304.0,"shares_display":"2,304","price_per_share":13.04,"price_display":"13.04","price_state":"stated","total_value":30044.16,"total_display":"30,044.16","total_whole":"30,044","shares_owned_after":16096.0,"shares_owned_after_display":"16,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-07","scope":"insider"},{"id":2120272,"accession":"0001209191-20-060097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-060097","line_url":"/filing/0001209191-20-060097#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001748265","owner_name":"Posner Christopher","owner_display_name":"Posner Christopher","owner_url":"/insider/0001748265","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":15.819,"price_display":"15.82","price_state":"stated","total_value":31638.0,"total_display":"31,638.00","total_whole":"31,638","shares_owned_after":11200.0,"shares_owned_after_display":"11,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-19","filed_date":"2020-11-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001346830","name":"Cara Therapeutics, Inc.","url":"/issuer/0001346830","role":"Director, Officer (PRESIDENT AND CEO)","n_filings":17,"first_seen":"2020-11-23","last_seen":"2025-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001748265","retrieved_at":"2026-08-25T06:38:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}